TY  - JOUR 
AU  - Bello López, José Luis
PY  - 2013
SN  - 0143-3636
UR  - http://hdl.handle.net/20.500.11940/3528
LA  - eng
TI  - Predictive value of interim 18F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment
DO  - 10.1097/MNM.0b013e328363c695
T2  - NUCLEAR MEDICINE COMMUNICATIONS
M2  - 946
VL  - 34
ER  -